Exhibit 99.2
September 24, 2021
Via Email (mmyers@quoinpharma.com)
Michael Myers, Ph.D.
Chief Executive Officer
Quoin Pharmaceuticals, Inc.
42127 Pleasant Forest Court
Ashburn, VA 20148
Re: | Agreement and Plan of Merger and Reorganization by and among Cellect Biotechnology, Inc. |
(“Cellect”), CellMSC, Inc. (“Merger Sub”), and Quoin Pharmaceuticals, Inc. (“Quoin”) dated as of | |
March 24, 2021 |
Dear Michael:
This letter sets forth our agreement to amend the Merger Agreement, as we discussed. Effective as of the date hereof, the “Outside Date” (as defined in the Merger Agreement) shall be November 1, 2021. In all other respects, the provisions of the Merger Agreement shall remain in full force and effect.
Please sign below to confirm your agreement to this amendment.
Sincerely,
Shai Yarkoni
CEO
CELLECT BIOTECHNOLOGY, LTD.
By: | /s/ Shai Yarkoni | |||
Shai Yarkoni | ||||
CEO | ||||
CELLMSC, INC. | QUOIN PHARMACEUTICALS, INC. | |||
By: | /s/ Shai Yarkoni | By: | /s/ Michael Myers | |
Shai Yarkoni | Michael Myers | |||
President | Chief Executive Officer |